2. See Ostacher et al., https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553693/
Coaches do not provide clinical assessments, recommendations, and/or diagnoses.
Freespira is indicated (FDA-cleared) as an adjunctive treatment of symptoms associated with panic disorder, panic attacks and/or PTSD in patients 18 and older.
*Freespira, Inc. is the maker of the Freespira treatment. Freespira, Inc. is a separate entity from Harvard Pilgrim Health Care. Harvard Pilgrim Health Care is offering Freespira treatment at no additional cost as a pilot program available to eligible commercial fully-insured Harvard Pilgrim Health Care members and their dependents aged 18 and older. Eligibility is determined by a symptom assessment and program availability is limited. Program and services subject to change. Freespira is a pilot program offered by Harvard Pilgrim and can end at any time.